Solubility of pioglitazone hydrochloride in binary and ternary mixtures of water, propylene glycol, and polyethylene glycols 200, 400, and 600 at 298.2 K

AAPS PharmSciTech

Volumn 11, Issue 4, 2010, Pages 1713-1717

  Jouyban, Abolghasem ^a   Soltanpour, Shahla ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cosolvency; Jouyban Acree model; pioglitazone hydrochloride; solubility

Indexed keywords

MACROGOL; MACROGOL 200; MACROGOL 400; MACROGOL 600; PIOGLITAZONE; PROPYLENE GLYCOL; SOLVENT; UNCLASSIFIED DRUG; WATER;

ARTICLE; DRUG MIXTURE; DRUG SOLUBILITY; PRIORITY JOURNAL;

DRUG COMPOUNDING; ETHANOL; EXCIPIENTS; HYPOGLYCEMIC AGENTS; MODELS, CHEMICAL; POLYETHYLENE GLYCOLS; PROPYLENE GLYCOL; SOLUBILITY; THIAZOLIDINEDIONES; WATER;

EID: 78651497867     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9551-4     Document Type: Article

References (29)

1. J Bradbury 2002 Explanation found for "glitazone paradox" Lancet. 360 1003 10.1016/S0140-6736(02)11125-1
2. BR Prashantha Kumar MJ Nanjan 2010 Novel glitazones: Design, synthesise, glucose uptake and structure-activity relationships Bioorg Med Chem Lett. 20 1953 6 10.1016/j.bmcl.2010.01.125
3. A Cohen A Rabbani N Shah G Caleb Alexander 2010 Changes in glitazone use among office-based physicians in the US, 2003-2009 Diabetes Care. 33 823 5 10.2337/dc09-1834 20103549
4. H Nakatsuji K Kishida I Shimomura 2010 Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes Atherosclerosis 212 243 5 1:CAS:528:DC%2BC3cXhtFams77I 10.1016/j.atherosclerosis.2010.05.025 20541758
5. Sakurai H, Iwamoto T. Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging 2009; doi: 10.1016/j.neurobiolaging. 2009.10.009.
6. N Seedher M Kanojia 2008 Micellar solubilization of some poorly soluble drugs: A technical note AAPS PharmSciTech. 9 431 6 10.1208/s12249-008-9057-5 1:CAS:528:DC%2BC3cXnslGjt78%3D 10.1208/s12249-008-9057-5 18431666
7. N Seedher M Kanojia 2009 Co-solvent solubilization of some poorly soluble antidiabetic drugs Pharm Develop Tech. 14 185 92 10.1080/10837450802498894 1:CAS:528:DC%2BD1MXks1Sqtrs%3D 10.1080/10837450802498894
8. Sh Soltanpour WE Acree Jr A Jouyban 2009 Solubility of pioglitazone hydrochloride in aqueous solutions of ethanol, propylene glycol, and N-methyl-2-pyrrolidone at 298.2 K AAPS PharmSciTech. 10 1153 7 1:CAS:528:DC%2BC3cXovVGqsb0%3D 10.1208/s12249-009-9322-2 19834813
9. A Jouyban Sh Soltanpour 2010 Solubility of pioglitazone hydrochloride in polyethylene glycol 600-ethanol-water mixtures at 25°C Latin Am J Pharm. 29 825 9 1:CAS:528:DC%2BC3cXht12msL%2FI
10. A Jouyban Sh Soltanpour 2010 Solubility of pioglitazone hydrochloride in binary mixtures of polyethylene glycol 400 with ethanol, propylene glycol, N-methyl-2-pyrrolidone, and water at 25°C Chem Pharm Bull. 58 1132 5 1:CAS:528:DC%2BC3cXhtlCqtb%2FM 10.1248/cpb.58.1132 20823589
11. A Avdeef 2007 Solubility of sparingly-soluble ionizable drugs Adv Drug Delivery Rev. 59 568 90 1:CAS:528:DC%2BD2sXpsFGksrs%3D 10.1016/j.addr.2007.05. 008 (Pubitemid 47285405)
12. Myrdal PB, Yalkowsky SH. Solubilization of Drugs. Encyclopedia of Pharmaceutical Technology. New York: Mercel Dekker Inc; 1999.
13. Harris JM. Poly (ethylene glycol) Chemistry, Biotechnical and Biomedical Application. New York: Plenum; 1992.
14. B Ballantyne HW Leung SJ Hermansky SW Frantz 1998 Subchronic, chronic, pharmacokinetic and genotoxicity studies with polyox water soluble resin Toxicol Lett. 1 46 7 10.1016/S0378-4274(98)80183-5
15. RG Strickley 2004 Solubilizing excipients in oral and injectable formulations Pharm Res. 21 201 30 1:CAS:528:DC%2BD2cXhtlWqt7o%3D 10.1023/B:PHAM.0000016235.32639.23 15032302 (Pubitemid 38221966)
16. SH Yalkowsky JT Rubino 1985 Solubilization by cosolvents I: Organic solutes in propylene glycol-water mixtures J Pharm Sci. 74 416 21 1:CAS:528:DyaL2MXkt1Oit7s%3D 10.1002/jps.2600740410 3999002 (Pubitemid 15112932)
17. Jouyban A. Handbook of Solubility Data for Pharmaceuticals. Boca Raton: CRC Press; 2009.
18. A Jouyban 2008 Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures J Pharm Pharmaceut Sci. 11 32 58 1:CAS:528:DC%2BD1MXht1ClsLjF
19. T Higuchi KA Connors 1965 Phase-solubility techniques Adv Anal Chem Instrum. 4 117 212 1:CAS:528:DyaF2MXktlGitrg%3D
20. A Jouyban WE Acree Jr 2009 Comments on "Solubility of ethyl maltol in aqueous ethanol mixtures" J Chem Eng Data. 54 1168 70 1:CAS:528:DC%2BD1MXhvFShsL0%3D 10.1021/je800798d
21. A Jouyban J Shokri M Barzegar-Jalali D Hassanzadeh WE Acree Jr T Ghafourian A Nokhodchi 2009 Solubility of chlordiazepoxide, diazepam, and lorazepam in ethanol+water mixtures at 303.2 K J Chem Eng Data. 54 2142 5 1:CAS:528:DC%2BD1MXkvVagtb8%3D 10.1021/je900200k
22. A Jouyban WE Acree Jr 2007 Prediction of drug solubility in ethanol-ethyl acetate mixtures at various temperatures using the Jouyban-Acree model J Drug Del Sci Tech. 17 159 60 1:CAS:528:DC%2BD2sXmtlWjs7s%3D
23. A Jouyban 2006 Solubility prediction of drugs in water-polyethylene glycol using Jouyban-Acree model Chem Pharm Bull. 54 1561 6 1:CAS:528: DC%2BD2sXjsFCnug%3D%3D 10.1248/cpb.54.1561 17077553 (Pubitemid 44703982)
24. A Jouyban Sh Soltanpour E Tamizi 2008 Solubility prediction of solutes in aqueous mixtures of ethylene glycols Pharmazie. 63 548 50 1:CAS:528: DC%2BD1cXovFWls7g%3D 18717495
25. A Kawakami K Miyoshi Y Ida 2005 Impact of the amount of excess solids on apparent solubility Pharm Res. 22 1537 43 1:CAS:528:DC%2BD2MXptVWlu74%3D 10.1007/s11095-005-6247-7 16132367 (Pubitemid 41215895)
26. Z Wang LS Burrell WJ Lambert 2002 Solubility of E2050 at various pH: A case in which apparent solubility is affected by the amount of excess solid J Pharm Sci. 91 1445 55 1:CAS:528:DC%2BD38XktlWrs7w%3D 10.1002/jps.10107 12115844 (Pubitemid 34633960)
27. Avdeef A, Voloboy D, Foreman A. Dissolution-solubility: pH, buffer, salt, dual-solid, and aggregation effects. In: Testa B, van de Waterbeemd H, editors. Comprehensive medicinal chemistry II, Vol. 5, ADME-TOX Approaches. Oxford: Elsevier; 2007. p. 399-423.
28. ow Ind Eng Chem Res. 37 4470 5 10.1021/ie980232v 1:CAS:528:DyaK1cXmtlKhu70%3D 10.1021/ie980232v
29. A Jouyban MAA Fakhree 2008 A new definition of solubilization power of a cosolvent Pharmazie. 63 317 19 10.1691/ph.2008.7288 1:CAS:528: DC%2BD1cXks1KgsLg%3D 18468394 (Pubitemid 351543033)